The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
Open accessAbstract
Altered gut microbiome is associated with systemic inflammation and cirrhosis decompensation. However, the correlation of the oral microbiome with inflammation in cirrhosis is unclear. Our aim was to evaluate the oral microbiome in cirrhosis and compare with stool microbiome. Outpatients with cirrhosis (with/without hepatic encephalopathy [HE]) and controls underwent stool/saliva microbiome analysis (for composition and function) and also systemic inflammatory evaluation. Ninety‐day liver‐related hospitalizations were recorded. Salivary inflammation was studied using T helper 1 cytokines/secretory immunoglobulin A (IgA), histatins and lysozyme in a subsequent group. A total of 102 patients with cirrhosis (43 previous HE) and 32 age‐matched controls were included. On principal component analysis (PCA), stool and saliva microbiome clustered far apart, showing differences between sites as a whole. In salivary microbiome, with previous HE, relative abundance of autochthonous families decreased whereas potentially pathogenic ones (Enterobacteriaceae, Enterococcaceae) increased in saliva. Endotoxin‐related predicted functions were significantly higher in cirrhotic saliva. In stool microbiome, relative autochthonous taxa abundance reduced in previous HE, along with increased Enterobacteriaceae and Enterococcaceae. Cirrhotic stool microbiota demonstrated a significantly higher correlation with systemic inflammation, compared to saliva microbiota, on correlation networks. Thirty‐eight patients were hospitalized within 90 days. Their salivary dysbiosis was significantly worse and predicted this outcome independent of cirrhosis severity. Salivary inflammation was studied in an additional 86 age‐matched subjects (43 controls/43 patients with cirrhosis); significantly higher interleukin (IL)−6/IL‐1β, secretory IgA, and lower lysozyme, and histatins 1 and 5 were found in patients with cirrhosis, compared to controls. Conclusions: Dysbiosis, represented by reduction in autochthonous bacteria, is present in both saliva and stool in patients with cirrhosis, compared to controls. Patients with cirrhosis have impaired salivary defenses and worse inflammation. Salivary dysbiosis was greater in patients with cirrhosis who developed 90‐day hospitalizations. These findings could represent a global mucosal‐immune interface change in cirrhosis. (H epatology 2015;62:1260‐1271)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies have demonstrated differences in the duodenal and salivary microbiota between healthy controls and patients with cirrhosis86,88, suggesting that there are also qualitative and quantitative changes in the upper gastrointestinal tract that might be linked to changes in the more distal microbiota and contribute to the pathophysiology of CLD as well as the development of HCC.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
Alterations of the human gut microbiome in liver cirrhosis
Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., et al. (2014) · Nature · doi:10.1038/nature13568 · Cited by 2,177
Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,599
Interaction between Phenolics and Gut Microbiota: Role in Human Health
Selma, M. V., Espín, J. C., & Tomás-Barberán, F. A. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf902107d · Cited by 1,324
Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut
Mantis, N. J., Rol, N., & Corthésy, B. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.41 · Cited by 1,283
Cited by
Sorted by citations
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480
Characterization of the gut microbiome using 16S or shotgun metagenomics
Jovel, J., Patterson, J., Wang, W., Hotte, N., O'Keefe, S., Mitchel, T., Perry, T., Kao, D., Mason, A. L., Madsen, K. L., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00459 · Cited by 942
Alcohol, liver disease and the gut microbiota
Bajaj, J. S. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0099-1 · Cited by 724
Self-citationThe gut microbiome and liver cancer: mechanisms and clinical translation
Yu, L.-X., & Schwabe, R. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.72 · Cited by 634
Intestinal Barrier in Human Health and Disease
Tommaso, N. D., Gasbarrini, A., & Ponziani, F. R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312836 · Cited by 577
Gut microbiome and liver diseases
Tilg, H., Cani, P. D., & Mayer, E. A. (2016) · Gut · doi:10.1136/gutjnl-2016-312729 · Cited by 525
Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy
Rose, C. F., Amodio, P., Bajaj, J. S., Dhiman, R. K., Montagnese, S., Taylor-Robinson, S. D., Vilstrup, H., & Jalan, R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.013 · Cited by 509
Self-citationGut microbiome, liver immunology, and liver diseases
Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00592-6 · Cited by 466
Cirrhosis-associated immune dysfunction
Albillos, A., Martín‐Mateos, R., der Merwe, V., Wiest, R., Jalan, R., & Álvarez‐Mon, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00520-7 · Cited by 485
Targeting the gut-liver axis in liver disease
Wiest, R., Albillos, A., Trauner, M., Bajaj, J. S., & Jalan, R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.007 · Cited by 427
Self-citationVallianou, N. G., Christodoulatos, G. S., Karampela, Ι., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D. C., & Dalamaga, Μ. (2021) · Biomolecules · doi:10.3390/biom12010056 · Cited by 305
The microbiota in cirrhosis and its role in hepatic decompensation
Trebicka, J., Macnaughtan, J., Schnabl, B., Shawcross, D. L., & Bajaj, J. S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.013 · Cited by 283
Self-citationLv, L., Fang, D., Shi, D., Chen, D., Yan, R., Zhu, Y., Chen, Y., Shao, L., Guo, F., Wu, W., et al. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.13401 · Cited by 245
Microbiota, cirrhosis, and the emerging oral-gut-liver axis
Acharya, C., Sahingur, S. E., & Bajaj, J. S. (2017) · JCI Insight · doi:10.1172/jci.insight.94416 · Cited by 260
Self-citationOral–Gut Microbiome Axis in Gastrointestinal Disease and Cancer
Park, S.-Y., Hwang, B.-O., Lim, M., Ok, S.-H., Lee, S., Chun, K., Park, K.-K., Hu, Y., Chung, W., & Song, N. (2021) · Cancers · doi:10.3390/cancers13092124 · Cited by 247
Patel, V., Lee, S., McPhail, M. J. W., Silva, K. D., Guilly, S., Zamalloa, A., Witherden, E. A., Støy, S. H., Vijay, G. K. M., Pons, N., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.010 · Cited by 240
Grąt, M., Wronka, K. M., Krasnodębski, M., Masior, Ł., Lewandowski, Z., Kosińska, I., Grąt, K., Stypułkowski, J., Rejowski, S., Wasilewicz, M. P., et al. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.01.077 · Cited by 211
Woodhouse, C., Patel, V., Singanayagam, A., & Shawcross, D. L. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14397 · Cited by 212
Oral microbiota: A new view of body health
Lu, M., Xuan, S., & Wang, Z. (2019) · Food Science and Human Wellness · doi:10.1016/j.fshw.2018.12.001 · Cited by 223
Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology
Chen, Y., Ji, F., Guo, J., Shi, D., Fang, D., & Li, L. (2016) · Scientific Reports · doi:10.1038/srep34055 · Cited by 205
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Trebicka, J., Bork, P., Krag, A. A., & Arumugam, M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00376-3 · Cited by 204
Solé, C., Guilly, S., Silva, K. D., Llopis, M., Chatelier, E. L., Huelin, P., Carol, M., Moreira, R., Fabrellas, N., de Prada, G., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.054 · Cited by 186
Maccioni, L., Gao, B., Leclercq, S., Pirlot, B., Horsmans, Y., De Timary, P., Leclercq, I., Fouts, D., Schnabl, B., & Stärkel, P. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1782157 · Cited by 174
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
Schwenger, K. J. P., Clermont‐Dejean, N. M., & Allard, J. P. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.04.004 · Cited by 179
Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
Bajaj, J. S., & Khoruts, A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.017 · Cited by 172
Self-citationPeriodontitis, chronic liver diseases, and the emerging oral‐gut‐liver axis
Albuquerque‐Souza, E., & Sahingur, S. E. (2022) · Periodontology 2000 · doi:10.1111/prd.12427 · Cited by 165
Altered Microbiome in Patients With Cirrhosis and Complications
Acharya, C., & Bajaj, J. S. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.008 · Cited by 164
Self-citationFerenci, P. (2017) · Gastroenterology report · doi:10.1093/gastro/gox013 · Cited by 161
Role of gut microbiota in liver disease
Albhaisi, S. A. M., Bajaj, J. S., & Sanyal, A. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00118.2019 · Cited by 155
Self-citationRole of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Fukui, H. (2019) · Diseases · doi:10.3390/diseases7040058 · Cited by 159
Liver–Microbiome Axis in Health and Disease
Adolph, T. E., Grander, C., Moschen, A. R., & Tilg, H. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.05.002 · Cited by 167
Ponziani, F. R., Zocco, M. A., Cerrito, L., Gasbarrini, A., & Pompili, M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1481747 · Cited by 139
Kuraji, R., Sekino, S., Kapila, Y. L., & Numabe, Y. (2021) · Periodontology 2000 · doi:10.1111/prd.12387 · Cited by 146
Sung, C. M., Lin, Y.-F., Chen, K.-F., Ke, H.-M., Huang, H.-Y., Gong, Y.-N., Tsai, W.-S., You, J.-F., Lu, M. J., Cheng, H.-T., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.008 · Cited by 127
Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma
Lu, H., Ren, Z., Li, A., Zhang, H., Jiang, J., Xu, S., Luo, Q., Zhou, K., Sun, X., Zheng, S., et al. (2016) · Scientific Reports · doi:10.1038/srep33142 · Cited by 129
Bajaj, J. S., Vargas, H. E., Reddy, K. R., Lai, J. C., O’Leary, J. G., Tandon, P., Wong, F. S.-H., Mitrani, R., White, M. B., Kelly, M., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.022 · Cited by 125
Self-citationGiuffrè, M., Campigotto, M., Campisciano, G., Comar, M., & Crocè, L. S. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00161.2019 · Cited by 122
Bajaj, J. S., Acharya, C., Fagan, A., White, M. B., Gavis, E. A., Heuman, D. M., Hylemon, P. B., Fuchs, M. A., Puri, P., Schubert, M. L., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0085-9 · Cited by 124
Self-citationPeriodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis
Bajaj, J. S., Matin, P., White, M. B., Fagan, A., Deeb, J. G., Acharya, C., Dalmet, S. S., Sikaroodi, M., Gillevet, P. M., & Sahingur, S. E. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00230.2018 · Cited by 122
Self-citationWang, W., Zhang, Y., Huang, X., You, N., Zheng, L., & Li, J. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i38.6983 · Cited by 114
Abe, K., Takahashi, A., Fujita, M., Imaizumi, H., Hayashi, M., Okai, K., & Ohira, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198757 · Cited by 110
Oral bacteria colonize and compete with gut microbiota in gnotobiotic mice
Li, B., Yang, G., Cheng, L., Zeng, B., Yu, J., Peng, X., Zhao, J., Li, W., Ren, B., Li, M., et al. (2019) · International Journal of Oral Science · doi:10.1038/s41368-018-0043-9 · Cited by 116
Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
Park, J. W., Kim, S. E., Lee, N. Y., Kim, J. H., Jung, J.-H., Jang, M.-K., Park, S.-H., Lee, M.-S., Kim, D.-J., Kim, H.-S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010426 · Cited by 110
The oral cavity microbiota: between health, oral disease, and cancers of the aerodigestive tract
Bars, P. L., Matamoros, S., Montassier, E., Vacon, F. L., Potel, G., Soueidan, A., Jordana, F., & de la Cochetière, M.-F. (2017) · Canadian Journal of Microbiology · doi:10.1139/cjm-2016-0603 · Cited by 111
Kjærgaard, K., Mikkelsen, A. C. D., Wernberg, C. W., Grønkjær, L. L., Eriksen, P. L., Damholdt, M. F., Mookerjee, R. P., Vilstrup, H., Lauridsen, M. M., & Thomsen, K. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040673 · Cited by 116
Gut microbiome and liver disease
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.005 · Cited by 106
Self-citationCircadian oscillations of microbial and functional composition in the human salivary microbiome
Takayasu, L., Suda, W., Takanashi, K., Iioka, E., Kurokawa, R., Shindo, C., Hattori, Y., Yamashita, N., Nishijima, S., Oshima, K., et al. (2017) · DNA Research · doi:10.1093/dnares/dsx001 · Cited by 102
Baltazar-Díaz, T. A., González-Hernández, L. A., Aldana-Ledesma, J. M., Rodríguez, M. P., Vega‐Magaña, N., Zepeda‐Morales, A. S. M., López-Roa, R. I., del Toro‐Arreola, S., Martínez‐López, E., Salazar-Montes, A. M., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10061231 · Cited by 104
Gut Microbiota and Complications of Liver Disease
Acharya, C., & Bajaj, J. S. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.013 · Cited by 101
Self-citationBajaj, J. S., Betrapally, N. S., Hylemon, P. B., Thacker, L. R., Daita, K., Kang, D. J., White, M. B., Unser, A. B., Fagan, A., Gavis, E. A., et al. (2015) · Scientific Reports · doi:10.1038/srep18559 · Cited by 92
Self-citationLau, L. H. S., & Wong, S. H. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_9 · Cited by 93
Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy
Mancini, A., Campagna, F., Amodio, P., & Tuohy, K. M. (2018) · Food & Function · doi:10.1039/c7fo01528c · Cited by 89
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma
Yang, J., He, Q., Lü, F., Chen, K., Ni, Z., Wang, H., Zhou, C., Zhang, Y., Chen, B., Bo, Z., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2201159 · Cited by 96
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications
Ponziani, F. R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12322 · Cited by 90
Nie, Y., Liu, Q., Zhang, W., Wan, Y., Huang, C., & Zhu, X. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1972746 · Cited by 88
Periodontitis is associated with incident chronic liver disease—A population‐based cohort study
Helenius‐Hietala, J., Suominen, A. L., Ruokonen, H., Knuuttila, M. L. E., Puukka, P. J., Jula, A., Meurman, J. H., & Åberg, F. O. (2018) · Liver International · doi:10.1111/liv.13985 · Cited by 87
The Contribution of the Human Oral Microbiome to Oral Disease: A Review
Morrison, A. G., Sarkar, S., Umar, S., Lee, S. T. M., & Thomas, S. M. (2023) · Microorganisms · doi:10.3390/microorganisms11020318 · Cited by 92
Bajaj, J. S., Sikaroodi, M., Fagan, A., Heuman, D. M., Gilles, H., Gavis, E. A., Fuchs, M. A., González‐Maeso, J., Nizam, S., Gillevet, P. M., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00194.2019 · Cited by 84
Self-citationSalivary microbial profiles in relation to age, periodontal, and systemic diseases
Lira‐Junior, R., Åkerman, S., Klinge, B., Boström, E. A., & Gustafsson, A. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189374 · Cited by 79
Acharya, C., & Bajaj, J. S. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.056 · Cited by 79
Self-citationInflammatory status in human hepatic cirrhosis
Martinez‐Esparza, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11522 · Cited by 80
Salivary microbiome in non-oral disease: A summary of evidence and commentary
Acharya, A., Chan, Y., Kheur, S. M., Jin, L., Watt, R. M., & Mattheos, N. (2017) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2017.07.019 · Cited by 77
Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis
Maslennikov, R. V., Poluektova, E. A., Zolnikova, O. Y., Sedova, A., Курбатова, А. А., Shulpekova, Y. O., Dzhakhaya, N., Kardasheva, S. S., Nadinskaia, M. Y., Леонидовна, Б. Е., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216502 · Cited by 79
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Zhang, Y., Li, Z.-J., Gou, H.-Z., Song, X., & Zhang, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.945368 · Cited by 77
Arab, J. P., Arrese, M. A., & Shah, V. H. (2019) · Hepatology Research · doi:10.1111/hepr.13473 · Cited by 76
Oral Dysbiosis in Pancreatic Cancer and Liver Cirrhosis: A Review of the Literature
Mohammed, H., Varoni, E. M., Cochis, A., Cordaro, M., Gallenzi, P., Patini, R., Staderini, E., Lajolo, C., Rimondini, L., & Rocchetti, V. (2018) · Biomedicines · doi:10.3390/biomedicines6040115 · Cited by 71
King, A. M., Zhang, Z., Glassey, E., Siuti, P., Clardy, J., & Voigt, C. A. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01524-6 · Cited by 69
The oral microbiome in autoimmune diseases: friend or foe?
Huang, X., Huang, X., Huang, Y., Zheng, J., Ye, L., Mai, Z., Zhao, X., Cui, L., & Huang, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03995-x · Cited by 76
The Link between Gut Microbiota and Hepatic Encephalopathy
Won, S., Oh, K., Gupta, H., Ganesan, R., Sharma, S. P., Jeong, J., Yoon, S. J., Jeong, M. K., Min, B. H., Hyun, J. Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168999 · Cited by 69
Publisher Correction: The gut–liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0031-8 · Cited by 70
Bajaj, J. S., Fagan, A., White, M. B., Wade, J. B., Hylemon, P. B., Heuman, D. M., Fuchs, M. A., John, B. V., Acharya, C., Sikaroodi, M., et al. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000102 · Cited by 69
Self-citationLitwinowicz, K., Choroszy, M., & Waszczuk, E. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1669629 · Cited by 72
Xiao, H., Fan, Y., Li, Y., Dong, J., Zhang, S., Wang, B., Liu, J., Liu, X., Fan, S., Guan, J., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.10.028 · Cited by 66
Gut‐liver axis: Potential mechanisms of action of food‐derived extracellular vesicles
Zhang, S., Wang, Q., Tan, D. E. L., Sikka, V., Ng, C. H., Xian, Y., Li, D., Muthiah, M. D., Chew, N., Storm, G., et al. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12466 · Cited by 71
The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma
Sanduzzi‐Zamparelli, M., Rocco, A., Compare, D., & Nardone, G. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617705576 · Cited by 60
Iwasawa, K., Suda, W., Tsunoda, T., Oikawa‐Kawamoto, M., Umetsu, S., Takayasu, L., Inui, A., Fujisawa, T., Morita, H., Sogo, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23870-w · Cited by 62
Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy
Luo, W., Guo, S., Zhou, Y., Zhao, J., Wang, M., Sang, L.-X., Chang, B., & Wang, B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.873160 · Cited by 62
An adaptive microbiome α-diversity-based association analysis method
Koh, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-36355-7 · Cited by 55
In-Depth Metaproteomics Analysis of Oral Microbiome for Lung Cancer
Jiang, X., Zhang, Y., Wang, H., Wang, Z., Hu, S., Cao, C., & Xiao, H. (2022) · Research · doi:10.34133/2022/9781578 · Cited by 54
The role of gut microbiota in liver disease development and treatment
Wang, L., & Wan, Y. Y. (2019) · Liver Research · doi:10.1016/j.livres.2019.02.001 · Cited by 53
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis
Campion, D., Giovo, I., Ponzo, P., Saracco, G. M., Balzola, F. A., & Alessandria, C. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i6.489 · Cited by 57
Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step
Fukui, H. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00008 · Cited by 55
Managing portal hypertension in patients with liver cirrhosis
Sauerbruch, T., Schierwagen, R., & Trebicka, J. (2018) · F1000Research · doi:10.12688/f1000research.13943.1 · Cited by 52
Role of the intestinal microbiome in liver fibrosis development and new treatment strategies
Zhou, R., Fan, X., & Schnabl, B. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.005 · Cited by 53
Hassouneh, R., & Bajaj, J. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020330 · Cited by 53
Self-citationOral Health and Liver Disease: Bidirectional Associations—A Narrative Review
Åberg, F. O., & Helenius‐Hietala, J. (2022) · Dentistry Journal · doi:10.3390/dj10020016 · Cited by 55
Lee, S., Arefaine, B., Begum, N., Stamouli, M., Witherden, E. A., Mohamad, M., Harzandi, A., Zamalloa, A., Cai, H., Williams, R. L., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.09.046 · Cited by 56
Oral microbial community analysis of the patients in the progression of liver cancer
Li, D., Xi, W., Zhang, Z., Ren, L., Deng, C., Chen, J., Sun, C., Zhang, N., & Xu, J. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104479 · Cited by 52
Liu, Y., Li, J., Jin, Y., Zhao, L., Zhao, F., Feng, J., Li, A., & Wei, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00963 · Cited by 51
Altered oral microbiota in chronic hepatitis B patients with different tongue coatings
Zhao, Y., Mao, Y., Tang, Y., Ni, M.-Z., Liu, Q., Wang, Y., Feng, Q., Peng, J., & Hu, Y. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i30.3448 · Cited by 53
Intestinal permeability in a patient with liver cirrhosis
Aguirre-Valádez, J., Rivera-Espinosa, L., Méndez-Guerrero, O., Chávez-Pacheco, J. L., Juárez, I. G., & Torre, A. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s115902 · Cited by 52
Salzano, F. A., Marino, L., Salzano, G., Botta, R. M., Cascone, G., Fiorenza, U. D., Selleri, C., & Casolaro, V. (2018) · Journal of Immunology Research · doi:10.1155/2018/2724951 · Cited by 49
Unique subgingival microbiota associated with periodontitis in cirrhosis patients
Jensen, A., Grønkjær, L. L., Holmstrup, P., Vilstrup, H., & Kilian, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-28905-w · Cited by 48
Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice
Bluemel, S., Wang, L., Kuelbs, C., Moncera, K. J., Torralba, M., Singh, H., Fouts, D. E., & Schnabl, B. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1595300 · Cited by 49
Mukherjee, S., Chopra, A., Karmakar, S., & Bhat, G. S. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2339260 · Cited by 54
Nutritional assessment in cirrhotic patients with hepatic encephalopathy
Romeiro, F. G. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i30.2940 · Cited by 47
The role of the gut microbiota in the pathology and prevention of liver disease
Altamirano-Barrera, A., Uribe, M., Chávez-Tapia, N. C., & Nuño‐Lámbarri, N. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.006 · Cited by 48
Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
Wang, X., Li, M., Niu, Y., Zhang, X., Yin, J., Zhao, C.-J., & Wang, R. (2019) · Disease Markers · doi:10.1155/2019/5945721 · Cited by 45
Li, M., Li, K., Tang, S., Lv, Y., Wang, Q., Wang, Z., Luo, B., Niu, J., Zhu, Y., Guo, W., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100448 · Cited by 42
Metadata
- Authors
- Bajaj, J. S., Betrapally, N. S., Hylemon, P. B., Heuman, D. M., Daita, K., White, M. B., Unser, A., Thacker, L. R., Sanyal, A. J., Kang, D. J., Sikaroodi, M., & Gillevet, P. M.
- Affiliations
- Virginia Commonwealth University (US)
- George Mason University (US)
- Corresponding author
- Bajaj, Jasmohan S.
- ORCID
- Venue
- Hepatology
- Published
- 2015-05-06
- Volume
- 62
- Issue
- 4
- Pages
- 1260-1271
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- PMC
- PMC4587995
- OpenAlex
- W1518286619
- Cited by
- 325
- References
- 43
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 28 · 2023: 38 · 2022: 22 · 2021: 50 · 2020: 35 · 2019: 34 · 2018: 33 · 2017: 21 · 2016: 16 · 2015: 14
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 CX001076)
- National Institute on Alcohol Abuse and Alcoholism (R01AA020203, RO1AA020203)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK087913)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- liver cirrhosis, hepatic encephalopathy, salivary microbiota, gut microbiota, dysbiosis, systemic inflammation, Enterobacteriaceae, Enterococcaceae, endotoxin, secretory IgA, histatins, lysozyme, interleukin-6, IL-1β, mucosal immunity, hepatic decompensation
- MeSH terms
- Gastrointestinal Microbiome, Feces, Female, Hepatic Encephalopathy, Humans, Inflammation, Intestines, Liver Cirrhosis, Male, Middle Aged, Saliva, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
